Renoprotection: Clues from knockout models of rare diseases

Kidney International

Volumn 63, Issue 2, 2003, Pages 764-766

  Abbate, Mauro ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Alport syndrome; Angiotensin converting enzyme inhibitors; Glomerular basement membrane; Podocyte; Proteinuria; Transforming growth factor

Indexed keywords

ANGIOTENSIN II ANTAGONIST; COLLAGEN TYPE 4; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAMIPRIL; TRANSFORMING GROWTH FACTOR BETA;

ALPORT SYNDROME; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; GENE MUTATION; GENE REPLACEMENT THERAPY; GENETIC HETEROGENEITY; GLOMERULUS BASEMENT MEMBRANE; HEYMANN NEPHRITIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; SPECIES DIFFERENCE; TREATMENT OUTCOME;

EID: 0037248733     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00791.x     Document Type: Editorial

References (10)

1. CALLIS L, VILA A, CARRERA M: Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 55:1051-1056, 1999
2. PROESMANS W, KNOCKAERT H, TROUET D: Enalapril in paediatric patients with Alport syndrome: Two years' experience. Eur J Pediatr 159:430-433, 2000
3. GROSS O, BEIROWSKI B, KOEPKE ML, et al: Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63:438-446, 2003
4. GRODECKI KM, GAINS MJ, BAUMAL R, et al: Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Path 117:209-225, 1997
5. MACCONI D, GHILARDI M, BONASSI ME, et al: Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 11:477-489, 2000
6. BENIGNI A, TOMASONI S, GAGLIARDINI E, et al: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12:941-948, 2001
7. ROHR C, PRESTEL J, HEIDET L, et al: The LIM-homeodomain transcription factor Lmx1B plays a crucial role in podocytes. J Clin Invest 109:1073-1082, 2002
8. ABBATE M, ZOJA C, MORIGI M, et al: Transforming growth factor-β1 is upregulated by podocytes in response to excess intraglomerular passage of proteins. A central pathway in progressive glomerulosclerosis. Am J Pathol 161:2177-2191, 2002
9. HEIKKILA P, TIBELL A, MORITA T, et al: Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 8:882-890, 2001
10. ZOJA C, CORNA D, ROTTOLI D, et al: How to fully protect the kidney in severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 12:2898-2908, 2002